Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Specific immunotherapy (SIT) refers to a treatment that controls allergic symptoms by improving the patient’s tolerance by administering gradually increasing doses of allergen extract. The mechanism of SIT is very complicated. Preliminary research showed that immunoglobulins are elevated in patients after SIT, and the increase in immunoglobulin sIgG4 is positively correlated with improvement of clinical symptoms. This project will investigate the mechanisms of specific immunotherapy in patients with allergic rhinitis and asthma. 40 patients with allergic rhinitis or asthma will be randomized into a SIT group (where house dust mite is used as the allergen for SIT) or a conventional treatment group (where patients are treated according to the rules of allergic rhinitis and asthma stated in established guidelines). TO BE CONT’D
Gail Gauvreau
Guangzhou Medical University
Life Sciences
McMaster University
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.